Dupilumab & Autoimmune Skin Disease Risk in Children
Dupilumab and Autoimmune Risk in Children: A Nuanced Assessment Recent analyses indicate a potential increased risk of new-onset autoimmune skin diseases, specifically psoriasis and inflammatory bowel disease (IBD), in children ... Read More